K9N7C7 (R1AB_MERS1) Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Replicase polyprotein 1ab UniProtKBInterProInteractive Modelling
7078 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
Host translation inhibitor nsp1 1-193; PRO_0000422439
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
MERS-CoV Nsp1 bound to the human 43S pre-initiation complex |
Heteromer A0A4W2DI10; O00303; O15371; O15372; O75821; P05198; P08708; P08865; P15880; P20042; P23396; P25398; P39019; P41091; P41567; P42677; P46781; P46782; P46783; P47813; P60228; P60866; P61247; P62081; P62241; P62244; P62249; P62263; P62269; P62273; P62277; P62280; P62701; P62753; P62841; P62847; P62851; P62854; P62857; P62861; P62945; P62979; P63220; P63244; Q14152; Q7L2H7; Q99613; Q9UBQ5; Q9Y262; | 4×ZN; 1×GTP; 116×MG; 1×MET; 129×UNX; | ||||
Assess | ||||||
MERS-CoV Nsp1 protein bound to the Human 40S Ribosomal subunit |
Heteromer P08708; P08865; P15880; P23396; P25398; P39019; P42677; P46781; P46782; P46783; P60866; P61247; P62081; P62241; P62244; P62249; P62263; P62266; P62269; P62273; P62277; P62280; P62701; P62753; P62841; P62847; P62851; P62854; P62857; P62861; P62945; P62979; P63220; P63244; | 97×MG; 3×ZN; | ||||
Assess |
Non-structural protein 2 194-853; PRO_0000422440
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7msw.1.A | monomer | 0.51 | 20.65 | |||
Assess |
Papain-like proteinase nsp3 854-2740; PRO_0000422441
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
The crystal structure of the MERS-CoV papain-like protease (C111S) with human ubiquitin |
Heteromer P0CG47; | 2×IPA; 1×ZN; | ||||
Assess | ||||||
Structure of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug … | monomer | 1×ZN; 7×ACT; | ||||
Assess | ||||||
The crystal structure of the MERS-CoV macro domain with ADP-ribose | monomer | 1×APR; | ||||
Assess |
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4rf1.1.A | monomer | 0.76 | 1×ZN; 3×PGO; | 99.38 | ||
Assess |
3C-like proteinase nsp5 3248-3553; PRO_0000422443
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL protease inactive … | homo-2-mer | 4×GOL; 3×NA; | ||||
Assess | ||||||
Structure of MERS 3CL protease in complex with the cyclopropane based inhibitor 17d | homo-2-mer | 2×P8C; 2×PJR; | ||||
Assess | ||||||
Structure of MERS 3CL protease in complex with the cyclopropane based inhibitor 16d | homo-2-mer | 2×P9R; | ||||
Assess | ||||||
Crystal structure of MERS 3CL protease in complex with a phenyl sulfane inhibitor | homo-2-mer | 2×UUR; 2×UV2; | ||||
Assess | ||||||
Crystal structure of MERS 3CL protease in complex with a dimethyl sulfinyl benzene inhibitor | homo-2-mer | 2×URR; 2×UO9; | ||||
Assess | ||||||
Structure of MERS 3CL protease in complex with the cyclopropane based inhibitor 16d (high resolutio… | homo-2-mer | 2×S9U; 2×SD6; | ||||
Assess | ||||||
Structure of MERS 3CL protease in complex with the cyclopropane based inhibitor 13c | homo-2-mer | 2×IRR; 2×PG4; | ||||
Assess | ||||||
Structure of MERS 3CL protease in complex with the cyclopropane based inhibitor 15d | homo-2-mer | 2×P8L; | ||||
Assess | ||||||
Crystal structure of MERS 3CL protease in complex with a p-fluorophenyl dimethyl sulfane inhibitor | homo-2-mer | 2×UTL; | ||||
Assess | ||||||
Crystal structure of MERS 3CL protease in complex with a m-fluorophenyl dimethyl sulfane inhibitor | homo-2-mer | 2×UTU; | ||||
Assess | ||||||
Crystal structure of MERS-CoV 3CLpro in complex with the non-covalent inhibitor WU-04 | homo-2-mer | 2×J7R; | ||||
Assess | ||||||
Structure of MERS 3CL protease in complex with the cyclopropane based inhibitor 14d | homo-2-mer | 2×IRK; 2×IUB; 2×PG4; | ||||
Assess | ||||||
Crystal structure of MERS-CoV main protease | homo-2-mer | |||||
Assess | ||||||
The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective in… | homo-2-mer | |||||
Assess | ||||||
Crystal structure of MERS main protease in complex with inhibitor YH-53 | homo-2-mer | 2×HUR; | ||||
Assess | ||||||
Crystal structure of MERS main protease in complex with S217622 | homo-2-mer | 2×7YY; | ||||
Assess | ||||||
Crystal structure of MERS-CoV 3CL protease in spacegroup P212121 | homo-2-mer | |||||
Assess | ||||||
Crystal structure of MERS main protease in complex with PF07304814 | homo-2-mer | 1×80I; | ||||
Assess | ||||||
Crystal structure of MERS main protease in complex with PF07321332 | homo-2-mer | 1×4WI; | ||||
Assess | ||||||
Crystal structure of MERS-CoV 3CL protease (C148A) in spacegroup P212121 | homo-2-mer | |||||
Assess | ||||||
Crystal structure of MERS-CoV 3CL protease (C148A) in spacegroup P212121,pH 9.0 | homo-2-mer | |||||
Assess |
RNA-directed RNA polymerase nsp12 4378-5310; PRO_0000422449
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6nur.1.A | monomer | 0.76 | 2×ZN; | 71.83 | ||
Assess | ||||||
6yyt.1.A | monomer | 0.74 | 2×ZN; | 71.21 | ||
Assess | ||||||
8urb.1.A | monomer | 0.73 | 2×ZN; | 60.00 | ||
Assess |
Helicase nsp13 5311-5908; PRO_0000422450
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7nng.1.A | monomer | 0.68 | 2×ZN; | 72.13 | ||
Assess | ||||||
7egq.1.M | monomer | 0.66 | 3×ZN; | 72.13 | ||
Assess |
Guanine-N7 methyltransferase nsp14 5909-6432; PRO_0000422451
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
5c8s.1.B | monomer | 0.64 | 2×ZN; 1×MG; 1×SAH; | 63.22 | ||
Assess |
Uridylate-specific endoribonuclease nsp15 6433-6775; PRO_0000422452
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
5yvd.1.A | monomer | 0.76 | 99.13 | |||
Assess |